{"nctId":"NCT00704418","briefTitle":"Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery","startDateStruct":{"date":"2008-06"},"conditions":["Cataract"],"count":156,"armGroups":[{"label":"Bromfenac","type":"EXPERIMENTAL","interventionNames":["Drug: Bromfenac"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Bromfenac","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Scheduled for cataract surgery\n\nExclusion Criteria:\n\n* Known hypersensitivity to bromfenac and salicylates","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Summed Ocular Inflammation Score (SOIS) of Zero","description":"Participants with SOIS of 0. Scale: 0=0 cells (complete absence); 0.5=1-5 cells; 1=6-15 cells (very slight); 2=16-25 cells (moderate); 3=26-50 cells (marked); 4=\\>50 cells (intense)","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36","spread":null},{"groupId":"OG001","value":"23","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants That Are Pain Free","description":"Participant description of being pain free (Score of none)taken from patient questionnaire, Ocular Comfort Grading Assessment with multiple possible responses","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"65","spread":null},{"groupId":"OG001","value":"40","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":73},"commonTop":["Eye Inflammation","Eye Pain","Corneal oedema"]}}}